<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dardas Z</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>Baylor-Hopkins Center for Mendelian Genomics</funding><funding>Foundation for the National Institutes of Health</funding><funding>Genomic Research Elucidates the Genetics of Rare disease</funding><funding>NINDS NIH HHS</funding><pagination>53</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10988827</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>NODAL signaling plays a critical role in embryonic patterning and heart development in vertebrates. Genetic variants resulting in perturbations of the TGF-β/NODAL signaling pathway have reproducibly been shown to cause laterality defects in humans. To further explore this association and improve genetic diagnosis, the study aims to identify and characterize a broader range of NODAL variants in a large number of individuals with laterality defects.&lt;h4>Methods&lt;/h4>We re-analyzed a cohort of 321 proband-only exomes of individuals with clinically diagnosed laterality congenital heart disease (CHD) using family-based, rare variant genomic analyses. To this cohort we added 12 affected subjects with known NODAL variants and CHD from institutional research and clinical cohorts t</pubmed_abstract><journal>Genome medicine</journal><pubmed_title>NODAL variants are associated with a continuum of laterality defects from simple D-transposition of the great arteries to heterotaxy.</pubmed_title><pmcid>PMC10988827</pmcid><funding_grant_id>UM1HG006542</funding_grant_id><funding_grant_id>UM1 HG011758</funding_grant_id><funding_grant_id>5RO1 HL091771</funding_grant_id><funding_grant_id>R35 NS105078</funding_grant_id><funding_grant_id>5RO1 HD039056</funding_grant_id><pubmed_authors>Bi W</pubmed_authors><pubmed_authors>Morris SA</pubmed_authors><pubmed_authors>Wehrens XHT</pubmed_authors><pubmed_authors>Grochowski CM</pubmed_authors><pubmed_authors>Muzny DM</pubmed_authors><pubmed_authors>Jhangiani SN</pubmed_authors><pubmed_authors>Posey JE</pubmed_authors><pubmed_authors>Jones EG</pubmed_authors><pubmed_authors>Liu P</pubmed_authors><pubmed_authors>Gibbs RA</pubmed_authors><pubmed_authors>Boerwinkle E</pubmed_authors><pubmed_authors>Jolly A</pubmed_authors><pubmed_authors>Coban-Akdemir Z</pubmed_authors><pubmed_authors>Fatih JM</pubmed_authors><pubmed_authors>Dardas Z</pubmed_authors><pubmed_authors>Du H</pubmed_authors><pubmed_authors>Dawood M</pubmed_authors><pubmed_authors>Lupski JR</pubmed_authors></additional><is_claimable>false</is_claimable><name>NODAL variants are associated with a continuum of laterality defects from simple D-transposition of the great arteries to heterotaxy.</name><description>&lt;h4>Background&lt;/h4>NODAL signaling plays a critical role in embryonic patterning and heart development in vertebrates. Genetic variants resulting in perturbations of the TGF-β/NODAL signaling pathway have reproducibly been shown to cause laterality defects in humans. To further explore this association and improve genetic diagnosis, the study aims to identify and characterize a broader range of NODAL variants in a large number of individuals with laterality defects.&lt;h4>Methods&lt;/h4>We re-analyzed a cohort of 321 proband-only exomes of individuals with clinically diagnosed laterality congenital heart disease (CHD) using family-based, rare variant genomic analyses. To this cohort we added 12 affected subjects with known NODAL variants and CHD from institutional research and clinical cohorts t</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-05-18T10:40:27.417Z</modification><creation>2025-05-18T10:40:27.417Z</creation></dates><accession>S-EPMC10988827</accession><cross_references><pubmed>38570875</pubmed><doi>10.1186/s13073-024-01312-9</doi></cross_references></HashMap>